Drug Discovery
Ginkgo and Boehringer Join Forces in a $406 Million Partnership to Uncover New Therapeutic Molecules
2023-05-11
Amylyx’s New ALS Drug Review Impeded as FDA Members Disagreed with Clinical Trial Results
2022-04-04
Roche Looks for Peptide-Like Small Molecules with Prism BioLab, joining Merck, Eisai and Boehringer Ingelheim
2022-01-05
HitGen Ink Deal with Cambridge Molecular to Create a Deep Learning-Driven Drug Discovery Platform
2021-11-08